News
Breast cancer drug also highly potent against leukaemia - Yahoo!
sg.news.yahoo.com
... acute myeloid leukaemia (AML) with FLT3 mutations, a study said. According to Iris Uras from the Institute of Pharmacology and Toxicology.
Drug against breast cancer is also highly potent against a frequent...
www.innovations-report.de
Photo: Iris Uras/Vetmeduni Vienna. In acute myeloid leukemia (AML), an activating mutation in the FLT3 tyrosine kinase is the most frequent ...
Vetmeduni : Iris Uras Jodl erhält Wilhelm Türk-Preis
www.vetmeduni.ac.at
Iris Uras Jodl vom Institut für Pharmakologie und Toxikologie an der Vetmeduni Vienna wurde mit dem heurigen Wilhelm Türk-Preis der Österreichischen...
Drug against breast cancer is also highly potent against a frequent...
www.bionity.com
Drug against breast cancer is also highly potent against a frequent form of leukaemia According to first author Iris Uras from the Institute of ...
sortiert nach Relevanz / Datum